E-DRUG:BMJ on US FDA in India (2)
-----------------------------------------------------------------------------------------------
Quality should not be compromised and at the same time protectionism is necessary.
The USA FDA has a right to apply its standards of quality and if it is Indian firms that get affected, so be it. Indian firms need to adapt and compete if they want a share of the US market that is too big to ignore.
[Small editorial changes have been made to improve readability: Moderator]
Best wishes,
Ibrahim Salahudeen Mohammed
Academic Pharmacist
Nigeria
Salahudeen <ibrasal2003@yahoo.com>